Structure and Characterization of a Covalent Inhibitor of Src Kinase.

Frontiers in Molecular Biosciences
Deepak GurbaniKenneth D Westover

Abstract

Unregulated Src activity promotes malignant processes in cancer, but no Src-directed targeted therapies are used clinically, possibly because early Src inhibitors produce off-target effects leading to toxicity. Improved selective Src inhibitors may enable Src-directed therapies. Previously, we reported an irreversible Src inhibitor, DGY-06-116, based on the hybridization of dasatinib and a promiscuous covalent kinase probe SM1-71. Here, we report biochemical and biophysical characterization of this compound. An x-ray co-crystal structure of DGY-06-116: Src shows a covalent interaction with the kinase p-loop and occupancy of the back hydrophobic kinase pocket, explaining its high potency, and selectivity. However, a reversible analog also shows similar potency. Kinetic analysis shows a slow inactivation rate compared to other clinically approved covalent kinase inhibitors, consistent with a need for p-loop movement prior to covalent bond formation. Overall, these results suggest that a strong reversible interaction is required to allow sufficient time for the covalent reaction to occur. Further optimization of the covalent linker may improve the kinetics of covalent bond formation.

References

Jun 1, 2002·Science·Donald P McDonnell, John D Norris
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Jul 21, 2006·Acta Crystallographica. Section D, Biological Crystallography·Wladek MinorMaksymilian Chruszcz
Jan 30, 2007·Endocrine-related Cancer·Stephen HiscoxRobert I Nicholson
Oct 23, 2008·International Journal of Cancer. Journal International Du Cancer·John Araujo, Christopher Logothetis
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Jul 4, 2009·Cancer Cell·Xiang H-F ZhangJoan Massagué
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Mar 17, 2010·Cancer Treatment Reviews·John Araujo, Christopher Logothetis
May 28, 2010·Journal of Cancer Science & Therapy·Amanda Gatesman AmmerScott A Weed
Nov 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Banibrata SenFaye M Johnson
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Martyn D WinnKeith S Wilson
Apr 28, 2011·The Oncologist·Lauren N PulsWells Messersmith
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Richard MarcotteWilliam J Muller
Jul 22, 2011·Journal of Signal Transduction·Banibrata Sen, Faye M Johnson
Dec 20, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adil I DaudWells A Messersmith
Jun 1, 2012·Blood·Daniela BuglioAnas Younes
Jul 28, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angeles Alvarez SecordRobert M Wenham
Aug 30, 2012·ACS Chemical Biology·Frank E KwarcinskiMatthew B Soellner
Nov 16, 2013·The Journal of Antimicrobial Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Dec 19, 2013·Proceedings of the National Academy of Sciences of the United States of America·Phillip A SchwartzBrion William Murray
Dec 24, 2013·Clinical Colorectal Cancer·Jiezhong ChenM Wasif Saif
May 3, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christine M Lovly, Alice T Shaw
Jun 10, 2014·The Journal of Clinical Investigation·Kang-Seo ParkGiuseppe Giaccone
Oct 12, 2015·Aging·Daniel Elias, Henrik J Ditzel
Oct 27, 2015·Nature Biotechnology·Jonathan M ElkinsWilliam J Zuercher
Apr 21, 2016·Molecular Pain·Milena De FeliceDavid Andrew
Aug 1, 2016·Breast Cancer Research and Treatment·Anne F SchottGabriel N Hortobagyi
Oct 28, 2016·Drug Design, Development and Therapy·Dilek KeskinAhmet Emre Eskazan
Dec 25, 2016·Bioorganic & Medicinal Chemistry·Li TanNathanael S Gray
Apr 24, 2018·Cell·Elizabeth A McMillanMichael A White
Apr 16, 2019·Cell Chemical Biology·Suman RaoNathanael S Gray
Apr 17, 2019·Journal of Cancer Research and Clinical Oncology·Jorge E CortesUNKNOWN BFORE Study Investigators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
surface plasmon resonance
biosensor

Clinical Trials Mentioned

NCT02954523

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.